Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area

References

• YuMCYuanJMEpidemiology of nasopharyngeal carcinomaSemin Cancer Biol200212642142912450728
   PubMed Web of Science ®Google Scholar
• WildemanMAFlesRAdhamMShort-term effect of different teaching methods on nasopharyngeal carcinoma for general practitioners in Jakarta, IndonesiaPLoS One201273e3275622431981
   PubMed Web of Science ®Google Scholar
• HuncharekMKupelnickBCombined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trialsAm J Clin Oncol200225321922312040275
   PubMed Web of Science ®Google Scholar
• TeoPMChanATTreatment strategy and clinical experienceSemin Cancer Biol200212649750412450735
   PubMed Web of Science ®Google Scholar
• TangLLLiWFChenLPrognostic value and staging categories of anatomic masticator space involvement in nasopharyngeal carcinoma: a study of 924 cases with MR imagingRadiology2010257115115720697119
   PubMed Web of Science ®Google Scholar
• AuJSLawCKFooWLauWHIn-depth evaluation of the AJCC/UICC 1997 staging system of nasopharyngeal carcinoma: prognostic homogeneity and proposed refinementsInt J Radiat Oncol Biol Phys200356241342612738316
   PubMed Web of Science ®Google Scholar
• FandiABachouchiMAzliNLong-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal typeJ Clin Oncol20001861324133010715304
   PubMed Web of Science ®Google Scholar
• MaBBLeungmSFHuiEPProspective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapyCancer2004101477678115305409
   PubMed Web of Science ®Google Scholar
• StokkelMPvan Eck-SmitBLZwindermanAHWillemsLNPauwelsEKPretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinomaJ Cancer Res Clin Oncol19981243–42152199619749
   PubMed Web of Science ®Google Scholar
• LiGGaoJTaoYLIncreased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinomaChin J Cancer201231419720622237040
   PubMedGoogle Scholar
• ChengSHTsaiSYHorngCFA prognostic scoring system for locoregional control in nasopharyngeal carcinoma following conformal radiotherapyInt J Radiat Oncol Biol Phys2006664992100316979832
   PubMed Web of Science ®Google Scholar
• ChengSHJianJJTsaiSYPrognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapyInt J Radiat Oncol Biol Phys19984147557629652835
   PubMed Web of Science ®Google Scholar
• TurenSOzyarEAltundagKGulluIAtahanILSerum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapyCancer Invest200725531532117661206
   PubMed Web of Science ®Google Scholar
• ZhouGQTangLLMaoYPBaseline serum lactate dehydrogenase levels for patients treated with intensity-modulated radiotherapy for nasopharyngeal carcinoma: a predictor of poor prognosis and subsequent liver metastasisInt J Radiat Oncol Biol Phys2012823e359e36522000748
   PubMed Web of Science ®Google Scholar
• WanXBWeiLLiHHigh pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinomaEur J Cancer201349102356236423541571
   PubMed Web of Science ®Google Scholar
• LiawCCWangCHHuangJSKiuMCChenJSChangHKSerum lactate dehydrogenase level in patients with nasopharyngeal carcinomaActa Oncol19973621591649140432
   PubMed Web of Science ®Google Scholar
• JinYYeXShaoLSerum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapyEur J Cancer20134971619162623266049
   PubMed Web of Science ®Google Scholar
• ChengSHTsaiSYYenKLConcomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinomaJ Clin Oncol200018102040204510811668
   PubMed Web of Science ®Google Scholar
• GreeneFLPageDLFlemingIDAJCC Cancer Staging Manual6th edNew YorkSpringer-Verlag2002
   Google Scholar
• FantinVRSt-PierreJLederPAttenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenanceCancer Cell20069642543416766262
   PubMed Web of Science ®Google Scholar
• LeACooperCRGouwAMInhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progressionProc Natl Acad Sci U S A201010752037204220133848
   PubMed Web of Science ®Google Scholar
• RademakersSELokJvan der KogelAJBussinkJKaandersJHMetabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1alpha, CAIX, LDH-5, GLUT-1, MCT1 and MCT4BMC Cancer20111116721569415
   PubMed Web of Science ®Google Scholar
• GatenbyRAGilliesRJWhy do cancers have high aerobic glycolysis?Nat Rev Cancer200441189189915516961
   PubMed Web of Science ®Google Scholar
• VaupelPThe role of hypoxia-induced factors in tumor progressionOncologist20049Suppl 5101715591418
   PubMed Web of Science ®Google Scholar
• GiatromanolakiASivridisEGatterKCTurleyHHarrisALKoukourakisMILactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosisGynecol Oncol2006103391291816837029
   PubMed Web of Science ®Google Scholar
• SchwartzMLactic dehydrogenase: an old enzyme reborn as a cancer marker?Am J Clin Pathol19919644414431892120
   PubMed Web of Science ®Google Scholar
• ByhardtRWHartzALibnochJAHansenRCoxJDPrognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL)Int J Radiat Oncol Biol Phys19861257717773011712
   PubMed Web of Science ®Google Scholar
• [No authors listed]A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors ProjectN Engl J Med1993329149879948141877
   PubMed Web of Science ®Google Scholar
• FranzkeAProbst-KepperMBuerJElevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanomaBr J Cancer199878140459662248
   PubMed Web of Science ®Google Scholar
• KolevYUetakeHTakagiYSugiharaKLactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosisAnn Surg Oncol20081582336234418521687
   PubMed Web of Science ®Google Scholar
• LukacovaSSorensenBSAlsnerJOvergaardJHorsmanMRThe impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour modelsActa Oncol200847594194717906983
   PubMed Web of Science ®Google Scholar
• KrishnaSMJamesSBalaramPExpression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV statusVirus Res20061151859016139912
   PubMed Web of Science ®Google Scholar
• JayasuryaABayBHYapWMTanNGLymphocytic infiltration in undifferentiated nasopharyngeal cancerArch Otolaryngol Head Neck Surg2000126111329133211074829
   PubMedGoogle Scholar
• RubioLBurgosJLopez-GuerreroJMoreraCVera-SempereFExpression of p53 protein and tumor angiogenesis as prognostic factors in nasopharyngeal carcinoma patientsPathol Res Pract200219829710211928871
   PubMed Web of Science ®Google Scholar
• KoukourakisMIGiatromanolakiASivridisEGatterKCHarrisALLactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway – a report of the Tumour Angiogenesis Research GroupJ Clin Oncol200624264301430816896001
   PubMed Web of Science ®Google Scholar
• HuiEPChanATPezzellaFCoexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survivalClin Cancer Res2002882595260412171890
   PubMed Web of Science ®Google Scholar
• HongBLuiVWHashiguchiMHuiEPChanATTargeting tumor hypoxia in nasopharyngeal carcinomaHead Neck201335113314522106024
   PubMed Web of Science ®Google Scholar
• BrizelDMSchroederTScherRLElevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancerInt J Radiat Oncol Biol Phys200151234935311567808
   PubMed Web of Science ®Google Scholar
• KoukourakisMIGiatromanolakiASivridisELactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosisBr J Cancer200389587788512942121
   PubMed Web of Science ®Google Scholar
• VerstovsekSKantarjianHEsteyEPlasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromeLeukemia20011581165117011480557
   PubMed Web of Science ®Google Scholar
• AuWYPangAChoyCChimCSKwongYLQuantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patientsBlood2004104124324915031209
   PubMed Web of Science ®Google Scholar
• WangZYLiuQFWangHClinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapyBlood2012120102003201022826562
   PubMed Web of Science ®Google Scholar
• WakisakaNKondoSYoshizakiTMuronoSFurukawaMPaganoJSEpstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alphaMol Cell Biol200424125223523415169887
   PubMed Web of Science ®Google Scholar
• O’NeilJDOwenTJWoodVHEpstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitroJ Gen Virol200889Pt 112833284218931081
   PubMed Web of Science ®Google Scholar
• LinJ-CJanJ-SHsuC-YLiangW-MJiangR-SWangW-YPhase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survivalJ Clin Oncol200321463163712586799
   PubMed Web of Science ®Google Scholar
• ChuaDTMaJShamJSLong-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trialsJ Clin Oncol20052361118112415657403
   PubMed Web of Science ®Google Scholar
• WeeJTanEHTaiBCRandomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varietyJ Clin Oncol200523276730673816170180
   PubMed Web of Science ®Google Scholar
• ZouGXieFJianmingGAnalysis of the prognosis for patients with stage T3N0∼ 1M0 nasopharyngeal carcinoma treated by chemotherapy combined with radiotherapyChinese Journal of Clinical Oncology20062313621366 Chinese
   Google Scholar
• LuoWGeWZhengYClinical study of docetaxel combined with concurrent radiotherapy in patients with advanced nasopharyngeal carcinomaThe Chinese-German Journal of Clinical Oncology20131212592595
   Google Scholar
• HareyamaMSakataKiShiratoHA prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinomaCancer20029482217222312001120
   PubMed Web of Science ®Google Scholar
• SunJ-DChenC-ZChenJ-ZLong term outcomes and prognostic factors of n0 stage nasopharyngeal carcinoma: a single institutional experience with 610 patientsAsian Pac J Cancer Prev20121352101210722901177
   PubMedGoogle Scholar
• SuS-FHanFZhaoCTreatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapyChin J Cancer201130856557321801605
   PubMedGoogle Scholar